These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33601665)

  • 1. Perfluorooctanesulfonate and perfluorooctanoate exacerbate airway inflammation in asthmatic mice and in vitro.
    Yang M; Li LY; Qin XD; Ye XY; Yu S; Bao Q; Sun L; Wang ZB; Bloom MS; Jalava P; Hu LW; Yu HY; Zeng XW; Yang BY; Dong GH; Li CW
    Sci Total Environ; 2021 Apr; 766():142365. PubMed ID: 33601665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic exposure to perfluorinated compounds: Impact on airway hyperresponsiveness and inflammation.
    Ryu MH; Jha A; Ojo OO; Mahood TH; Basu S; Detillieux KA; Nikoobakht N; Wong CS; Loewen M; Becker AB; Halayko AJ
    Am J Physiol Lung Cell Mol Physiol; 2014 Nov; 307(10):L765-74. PubMed ID: 25217661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion.
    Qazi MR; Bogdanska J; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Toxicology; 2009 Aug; 262(3):207-14. PubMed ID: 19540903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorooctanesulfonate (PFOS) and perfluorooctanoic acid (PFOA) modify
    Kasten-Jolly J; Lawrence DA
    J Toxicol Environ Health A; 2022 Sep; 85(17):715-737. PubMed ID: 35611390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells.
    Midgett K; Peden-Adams MM; Gilkeson GS; Kamen DL
    J Appl Toxicol; 2015 May; 35(5):459-65. PubMed ID: 25056757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans.
    Chang ET; Adami HO; Boffetta P; Cole P; Starr TB; Mandel JS
    Crit Rev Toxicol; 2014 May; 44 Suppl 1():1-81. PubMed ID: 24793953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice.
    Ngo HT; Hetland RB; Sabaredzovic A; Haug LS; Steffensen IL
    Environ Res; 2014 Jul; 132():251-63. PubMed ID: 24834819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NO
    Han M; Ji X; Li G; Sang N
    Environ Sci Pollut Res Int; 2017 Dec; 24(36):27843-27854. PubMed ID: 28986735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function and isomers of perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS): Isomers of C8 Health Project in China.
    Wang J; Zeng XW; Bloom MS; Qian Z; Hinyard LJ; Belue R; Lin S; Wang SQ; Tian YP; Yang M; Chu C; Gurram N; Hu LW; Liu KK; Yang BY; Feng D; Liu RQ; Dong GH
    Chemosphere; 2019 Mar; 218():1042-1049. PubMed ID: 30609483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the cytotoxicity and modulation of mechanisms associated with inflammation induced by perfluorooctanesulfonate and perfluorooctanoic acid in human colon myofibroblasts CCD-18Co.
    Giménez-Bastida JA; Surma M; Zieliński H
    Toxicol In Vitro; 2015 Oct; 29(7):1683-91. PubMed ID: 26142696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans.
    Chang ET; Adami HO; Boffetta P; Wedner HJ; Mandel JS
    Crit Rev Toxicol; 2016; 46(4):279-331. PubMed ID: 26761418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs).
    Corsini E; Avogadro A; Galbiati V; dell'Agli M; Marinovich M; Galli CL; Germolec DR
    Toxicol Appl Pharmacol; 2011 Jan; 250(2):108-16. PubMed ID: 21075133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
    Bjork JA; Butenhoff JL; Wallace KB
    Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study.
    Midasch O; Drexler H; Hart N; Beckmann MW; Angerer J
    Int Arch Occup Environ Health; 2007 Jul; 80(7):643-8. PubMed ID: 17219182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy.
    Fei C; McLaughlin JK; Lipworth L; Olsen J
    Environ Health Perspect; 2008 Oct; 116(10):1391-5. PubMed ID: 18941583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial responses to perfluoroalkyl substances and perfluorooctanesulfonate (PFOS) desulfurization in the Antarctic marine environment.
    Cerro-Gálvez E; Roscales JL; Jiménez B; Sala MM; Dachs J; Vila-Costa M
    Water Res; 2020 Mar; 171():115434. PubMed ID: 31927092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of daily intakes on the isomeric profiles of perfluoroalkyl substances (PFASs) in human serum.
    Shan G; Wang Z; Zhou L; Du P; Luo X; Wu Q; Zhu L
    Environ Int; 2016; 89-90():62-70. PubMed ID: 26826363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorooctanesulfonate and perfluorooctanoate in raw and treated tap water from Osaka, Japan.
    Takagi S; Adachi F; Miyano K; Koizumi Y; Tanaka H; Mimura M; Watanabe I; Tanabe S; Kannan K
    Chemosphere; 2008 Aug; 72(10):1409-1412. PubMed ID: 18602659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway exposure to perfluorooctanoate exacerbates airway hyperresponsiveness and downregulates glucocorticoid receptor expression in asthmatic mice.
    Zeng Z; Ma W; Zhao R; Dong X
    Transl Pediatr; 2021 Feb; 10(2):323-332. PubMed ID: 33708518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.